FDA Approves New Higher-Dose Wegovy for Weight Loss

The FDA has approved Wegovy HD, a higher-dose semaglutide, for weight loss in adults with obesity, offering a 'major jump' in potential weight reduction, with some users losing an average of 21 percent of their body weight.